Rexel Sa Ord (RXLSF) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. This is the conference operator. Welcome and thank you for joining the Rex Health third quarter 2025 sales conference call. As a reminder, all participants are in a listen-only mode. After the presentation, there will be an opportunity to ask questions. Should anyone need assistance during the conference call, they may signal an operator by pressing star and zero on their telephone. At this time, I would like to turn the conference over to Mr. Guillaume Texier, Group CEO of Rexel. Please go ahead, sir. Good morning, everyone, and thank you for joining us today for our third quarter 2025 sales presentation. I appreciate you making the time to be with us so early. As always, I'm joined by Laurent Delabarre, our Group CFO, who will walk you through the detailed sales figure in just a few minutes. But first, I'd like to take a look at the key highlights of the quarter and share how our transformation continues to support our growth and performance, even in a complex and evolving environment. So let's get started. We delivered a solid top-line momentum with Q3 2025 being the sixth consecutive quarter of sequential improvement. We are also maintaining a rigorous pricing and we keep investing with discipline where demand is strongest. At the same time, we are progressing on our Accelerate 2028 roadmap, raising digital adoption, deploying AI to improve speed and accuracy across commercial and operations, and reinforcing the balance sheet. You saw in our press release that we delivered 4.8 billion euros of sales in Q3 2025, up 3% on a same-day basis, with North America continuing to be our primary growth engine. Three key highlights to keep in mind. First, the momentum is driven by high growth segments where we are investing with success. Data centers and broadb...